TenNor Therapeutics (Suzhou) Limited (HKG:6872)
Hong Kong · Delayed Price · Currency is HKD 168.00
-5.80 (-3.34%)
Sep 4, 2026, 4:08 PM HKT
HKG:6872 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 714.73 | 183.77 | 97.82 | 58.11 |
Cash & Short-Term Investments | 714.73 | 183.77 | 97.82 | 58.11 |
Cash Growth | - | 87.86% | 68.33% | - |
Other Receivables | - | 0.01 | 2.7 | 2.29 |
Receivables | - | 0.01 | 2.7 | 2.29 |
Other Current Assets | 6.08 | 7.57 | 1.41 | 3.24 |
Total Current Assets | 720.8 | 191.35 | 101.93 | 63.64 |
Property, Plant & Equipment | 3.96 | 2.87 | 1.57 | 4.27 |
Other Intangible Assets | 25.38 | 25.4 | 25.32 | 25.42 |
Other Long-Term Assets | 10.42 | 7.42 | 4.07 | 2.72 |
Total Assets | 760.57 | 227.04 | 132.89 | 96.05 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 6.49 | 7.98 | 15.99 | 22.96 |
Accrued Expenses | - | 7.43 | 4.24 | 4.09 |
Short-Term Debt | 28.52 | 8.51 | 24.52 | 15.02 |
Current Portion of Long-Term Debt | 2.93 | 9.17 | 19.5 | 19.21 |
Current Portion of Leases | 0.89 | 0.94 | 0.16 | 1.24 |
Current Income Taxes Payable | - | 0.43 | 0.65 | 0.53 |
Other Current Liabilities | 9.96 | 3.7 | 0.53 | 767.97 |
Total Current Liabilities | 48.79 | 38.14 | 65.6 | 831.01 |
Long-Term Debt | 31.4 | 9.1 | 8.75 | 23.73 |
Long-Term Leases | 0.5 | 0.94 | 0.09 | 0.23 |
Other Long-Term Liabilities | 25 | 25 | 956.5 | 0 |
Total Liabilities | 105.69 | 73.18 | 1,031 | 854.96 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 52.33 | 43.47 | 38.87 | 36.58 |
Additional Paid-In Capital | 700.39 | 153.27 | - | - |
Retained Earnings | -176.34 | -112.1 | -929.6 | -783.67 |
Treasury Stock | - | - | -644.73 | -546.42 |
Comprehensive Income & Other | 78.5 | 69.21 | 637.42 | 534.61 |
Shareholders' Equity | 654.88 | 153.86 | -898.05 | -758.91 |
Total Liabilities & Equity | 760.57 | 227.04 | 132.89 | 96.05 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 64.24 | 28.65 | 53.02 | 59.42 |
Net Cash (Debt) | 650.49 | 155.11 | 44.79 | -1.31 |
Net Cash Growth | - | 246.28% | - | - |
Net Cash Per Share | 15.44 | 3.89 | 1.19 | -0.04 |
Filing Date Shares Outstanding | 52.33 | 43.47 | 37.52 | 36.96 |
Total Common Shares Outstanding | 52.33 | 43.47 | 37.52 | 36.96 |
Working Capital | 672.02 | 153.21 | 36.33 | -767.37 |
Book Value Per Share | 12.51 | 3.54 | -23.93 | -20.54 |
Tangible Book Value | 629.5 | 128.46 | -923.37 | -784.33 |
Tangible Book Value Per Share | 12.03 | 2.95 | -24.61 | -21.22 |
Machinery | - | 3.76 | 3.81 | 4.14 |
Leasehold Improvements | - | 3.91 | 3.91 | 3.81 |